Celgene Corp, which only a year ago entered a 10-year collaboration with Juno Therapeutics, has now invested in Jounce Therapeutics Inc which has different technology for stimulating the immune system to fight cancer. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
